Thermo Fisher – Simplify Allergy Diagnostics

Empower confident decision-making in frontline care with selected, clinically relevant allergen profiles

Optimise allergy diagnostics with ImmunoCAP Specific IgE profiles to support clinically guided, quantitative decision-making

Allergic diseases are common and often multifactorial.^1,2 When allergy diagnostics are based on patient history and clinically relevant testing, they bring clarity from the very beginning and support more confident clinical decision-making.¹

ImmunoCAP Specific IgE profiles provide quantitative results that give clear insight into clinically relevant sensitisation. This supports more informed diagnosis and patient management.³

This clinically guided allergen profile approach supports targeted testing and helps avoid reliance on broad, non-specific multiplex panels.¹ A consistent approach to allergen selection using locally adapted, clinically relevant profiles helps identify sensitisation patterns, including polysensitised patients, and supports confident diagnosis, informed management, and well-defined referral decisions.^1,3

References:

1. Santos AF, et al. EAACI guidelines on the diagnosis of IgE-mediated food allergy. Allergy. 2025;80(1):14-36.

2. Matricardi PM, et al. EAACI Molecular Allergology User’s Guide. Pediatr Allergy Immunol. 2016;27 (Suppl 23):1-250.

3. Demoly P, et al. Pragmatic primary practice approach to using specific IgE in allergy diagnosis. J Asthma Allergy. 2022;15:1069–1080.

---

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.